Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip Acquires Intravenous Therapy Services; Establishes West Coast Platform for Specialty Infusion Operations; BioScrip Increases Existing Credit Facility to $65 Million
ELMSFORD, N.Y.--(BUSINESS WIRE)--March 2, 2006--BioScrip, Inc. (NASDAQ: BIOS) today announced that it has acquired Intravenous Therapy Services ("ITS"), a specialty infusion company located in Burbank, California. In addition, the Company announced that it has increased its existing revolving
Toggle Summary BioScrip Acquires Northland Pharmacy; Expands Community Pharmacy Model
ELMSFORD, N.Y. & MINNEAPOLIS, Oct 11, 2005 (BUSINESS WIRE) -- BioScrip, Inc. (NASDAQ:BIOS) today announced that it has acquired Northland Medical Pharmacy ("Northland"), a community-based specialty pharmacy, located in Columbus, Ohio. Henry F. Blissenbach, BioScrip's President and Chief Executive
Toggle Summary BioScrip and Home Solutions Enter Into Amended Agreement
Amendment Further Enhances Value for Shareholders Accretive Transaction Provides Substantial Operating Synergies and Deleveraging Opportunity DENVER and HAMMONTON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of
Toggle Summary BioScrip and Home Solutions Enter Into Amended Asset Purchase Agreement to Expedite Closing
DENVER and HAMMONTON, N.J. , Sept. 02, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions and HS Infusion Holdings, Inc. ("Home Solutions"), today announced that they have further amended
Toggle Summary BioScrip and United Healthcare to Exit Specialty Services Agreement in 2009
Financial Impact Estimated at $2.0 Million for 2009 ELMSFORD, N.Y., Sep 11, 2008 (BUSINESS WIRE) -- BioScrip, Inc. (Nasdaq: BIOS) announced today that UnitedHealthcare, a UnitedHealth Group (NYSE: UHG) company, has notified the Company of its intention to internalize services for HIV/AIDS and Solid
Toggle Summary BioScrip Announces 2013 Investor Day
ELMSFORD, N.Y. , Sept. 11, 2013 /PRNewswire/ --  BioScrip®, Inc. (NASDAQ: BIOS) today announced its inaugural Investor Day to be held Tuesday, September 24, 2013 , at Le Parker Meridien located at 119 West 56th Street in New York City . (Logo: http://photos.prnewswire.com/prnh/20130117/NY44138LOGO
Toggle Summary BioScrip Announces Additions to Senior Leadership Team
Appoints Harriet Booker as Senior Vice President, Chief Operating Officer and Danny R. Claycomb as Senior Vice President, Revenue Cycle Management DENVER , Nov. 28, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of
Toggle Summary BioScrip Announces Amendment to Credit Agreement and New Senior Loan Facility
DENVER , Jan. 06, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it has entered into an agreement to amend its existing Credit Agreement (the “Amendment”), dated
Toggle Summary BioScrip Announces an $80 Million After-Tax Non-Cash Impairment Charge
Reaffirms Guidance ELMSFORD, N.Y. --(BUSINESS WIRE)-- BioScrip, Inc. (Nasdaq: BIOS), announced today that it will record a fourth quarter non-cash, after-tax charge of approximately $80.0 million for the impairment of goodwill and the write off of intangible assets in accordance with Statement of
Toggle Summary BioScrip Announces Availability of ALS Home Infusion Therapy
DENVER , Oct. 05, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, is pleased to announce that it can now dispense and administer Radicava® (edaravone), the first treatment